Allevi
Founded in 2014, Allevi's mission is to make it easy to design and engineer 3D tissues using desktop 3D bioprinters that are versatile, powerful, and easy-to-use. Allevi's 3D bioprinters and bioinks are trusted by leading researchers and industry giants in hundreds of labs globally in the fields of tissue engineering, organ-on-a-chip research, pharmaceutical validation, biomaterial development, and regenerative medicine.
Last updated on
About Allevi
Founded
2014Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$5MCategory
Location
City
PhiladelphiaState
PennsylvaniaCountry
United StatesAllevi
Find your buyer within Allevi